Evaluation of pulmonary infiltrates in patients after stem cell transplantation

Hematology

Volumn 10, Issue 6, 2005, Pages 469-481

  Scaglione, Steve ^a   Hofmeister, Craig C ^b,d   Stiff, Patrick ^c  

^a Internal Medicine Residency Program   (United States)

^b Stem Cell Transplantation Fellow   (United States)

^c LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^d Division of Hematology/Oncology   (United States)

Author keywords

Aspergillus; Bone marrow transplantation; Bronchoalveolar lavage; Bronchoscopy; Cytomegalovirus; Hematopoietic stem cell transplantation; Lung injury; Pneumonia

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; BUSULFAN; CARMUSTINE; ETANERCEPT; FLUCONAZOLE; GALACTOMANNAN; METHOTREXATE; METHYLPREDNISOLONE; PIPERACILLIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BRONCHOSCOPY; DISEASE CLASSIFICATION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION RISK; LUNG ALVEOLITIS; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG HEMORRHAGE; LUNG INFECTION; LUNG INFILTRATE; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

BRONCHOALVEOLAR LAVAGE; HUMANS; LUNG DISEASES; STEM CELL TRANSPLANTATION;

EID: 31144448662     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500180711     Document Type: Review

References (140)

1. Gatti, RA and Meuwissen, HJ and Allen, HD and Hong, R and Good, RA. (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency Lancet, 2(7583), pp. 1366-1369.
2. Anonymous, Annual numbers of blood and marrow transplants worldwide 1970-2002. www.ibmtr.org/summarysldset 2005;The 2003 BMT Summary Slides with Guide.
3. Anonymous, Allogeneic transplants in patients > 20 years registered with IBMTR, 1989-2002. www.ibmtr.org/summarysldset 2005;The 2003 BMT Summary Slides with Guide.
4. NMDP. 2003. www.nmdpresearch.org. Accessed.
5. Keil, F and Prinz, E and Moser, K and Mannhalter, C and Kalhs, P and Worel, N and Rabitsch, W and Schulenburg, A and Mitterbauer, M and Greinix, H. (2003) Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival Transplantation, 76(1), pp. 230-236.
6. Yang, MH and Chiou, TJ and Chao, TC and Hsiao, LT and Chen, PM. (2003) Delayed rejection after initial engraftment in non-myeloablative bone marrow transplantation J Chin Med Assoc, 66(11), pp. 682-688.
7. Marr, KA and Carter, RA and Boeckh, M and Martin, P and Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors Blood, 100(13), pp. 4358-4366.
8. Denning, DW. (1998) Invasive aspergillosis Clin Infect Dis, 26(4), pp. 781-803. quiz 804-5
9. Krowka, MJ and Rosenow, EC, 3rd. (1985) Hoagland HC. Pulmonary complications of bone marrow transplantation Chest, 87(2), pp. 237-246.
10. Reed, EC. (1993) Infectious complications during autotransplantation Hematol Oncol Clin North Am, 7(3), pp. 717-735.
11. Witherspoon, RP and Storb, R and Ochs, HD and Fluornoy, N and Kopecky, KJ and Sullivan, KM and Deeg, JH and Sosa, R and Noel, DR and Atkinson, K and and others. (1981) Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment Blood, 58(2), pp. 360-368.
12. Witherspoon, RP and Matthews, D and Storb, R and Atkinson, K and Cheever, M and Deeg, HJ and Doney, K and Kalbfleisch, J and Noel, D and Prentice, R and and others. (1984) Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease Transplantation, 37(2), pp. 145-150.
13. Winston, DJ and Territo, MC and Ho, WG and Miller, MJ and Gale, RP and Golde, DW. (1982) Alveolar macrophage dysfunction in human bone marrow transplant recipients Am J Med, 73(6), pp. 859-866.
14. Atkinson, K. (1986) T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry Bone Marrow Transplant, 1(2), pp. 121-132.
15. Warren, HS and Atkinson, K and Pembrey, RG and Biggs, JC. (1983) Human bone marrow allograft recipients: Production of, and responsiveness to, interleukin 2 J Immunol, 131(4), pp. 1771-1775.
16. Dykewicz, CA. (2001) Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients Clin Infect Dis, 33(2), pp. 139-144.
17. Lyytikainen, O and Ruutu, T and Volin, L and Lautenschlager, I and Jokipii, L and Tiittanen, L and Ruutu, P. (1996) Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation Bone Marrow Transplant, 17(6), pp. 1057-1059.
18. Goodrich, JM and Bowden, RA and Fisher, L and Keller, C and Schoch, G and Meyers, JD. (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant Ann Intern Med, 118(3), pp. 173-178.
19. Sakamaki, H and Yuasa, K and Goto, H and Tanikawa, S and Akiyama, H and Onozawa, Y and Okamoto, R and Maeda, Y and Sasaki, T and Kaku, H and and others. (1997) Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation Bone Marrow Transplant, 20(2), pp. 143-147.
20. Winston, DJ and Ho, WG and Bartoni, K and Du Mond, C and Ebeling, DF and Buhles, WC and Champlin, RE. (1993) Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial Ann Intern Med, 118(3), pp. 179-184.
21. Winston, DJ and Yeager, AM and Chandrasekar, PH and Snydman, DR and Petersen, FB and Territo, MC. (2003) Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation Clin Infect Dis, 36(6), pp. 749-758.
22. Reich, G and Mapara, MY and Reichardt, P and Dorken, B and Maschmeyer, G. (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: Comparison between patients with lymphoma or multiple myeloma and patients with solid tumors Bone Marrow Transplant, 27(5), pp. 525-529.
23. Mossad, SB and Longworth, DL and Goormastic, M and Serkey, JM and Keys, TF and Bolwell, BJ. (1996) Early infectious complications in autologous bone marrow transplantation: A review of 219 patients Bone Marrow Transplant, 18(2), pp. 265-271.
24. Kruger, W and Russmann, B and Kroger, N and Salomon, C and Ekopf, N and Elsner, HA and Kaulfers, PM and Mack, D and Fuchs, N and Durken, M and and others. (1999) Early infections in patients undergoing bone marrow or blood stem cell transplantation - A 7 year single centre investigation of 409 cases Bone Marrow Transplant, 23(6), pp. 589-597.
25. Martino, R and Caballero, MD and Canals, C and San Miguel, J and Sierra, J and Rovira, M and Solano, C and Bargay, J and Perez-Simon, J and Leon, A and and others. (2001) Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation Bone Marrow Transplant, 28(4), pp. 341-347.
26. Chen, CS and Boeckh, M and Seidel, K and Clark, JG and Kansu, E and Madtes, DK and Wagner, JL and Witherspoon, RP and Anasetti, C and Appelbaum, FR and and others. (2003) Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation Bone Marrow Transplant, 32(5), pp. 515-522.
27. Brown, PD. and Lerner, SA. (1998) Community-acquired pneumonia Lancet, 352(9136), pp. 1295-1302.
28. Souza, JP and Boeckh, M and Gooley, TA and Flowers, ME and Crawford, SW. (1999) High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis Clin Infect Dis, 29(6), pp. 1467-1471.
29. Clark, JG and Hansen, JA and Hertz, MI and Parkman, R and Jensen, L and Peavy, HH. (1993) NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation Am Rev Respir Dis, 147(6 Pt 1) 1601-1606
30. Cooke, KR and Kobzik, L and Martin, TR and Brewer, J and Delmonte, J, Jr and Crawford, JM and Ferrara, JL. (1996) An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin Blood, 88(8), pp. 3230-3239.
31. Cooke, KR and Hill, GR and Gerbitz, A and Kobzik, L and Martin, TR and Crawford, JM and Brewer, JP and Ferrara, JL. (2000) Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation J Immunol, 165(11), pp. 6612-6619.
32. Rubio, C and Hill, ME and Milan, S and O'Brien, ME and Cunningham, D. (1997) Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease Br J Cancer, 75(7), pp. 1044-1048.
33. Wingard, JR and Mellits, ED and Sostrin, MB and Chen, DY and Burns, WH and Santos, GW and Vriesendorp, HM and Beschorner, WE and Saral, R. (1988) Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution Medicine, 67(3), pp. 175-186.
34. Wingard, JR and Sostrin, MB and Vriesendorp, HM and Mellits, ED and Santos, GW and Fuller, DJ and Braine, HG and Yeager, AM and Burns, WH and Saral, R. (1988) Interstitial pneumonitis following autologous bone marrow transplantation Transplantation, 46(1), pp. 61-65.
35. Weiner, RS and Bortin, MM and Gale, RP and Gluckman, E and Kay, HE and Kolb, HJ and Hartz, AJ and Rimm, AA. (1986) Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors Ann Int Med, 104(2), pp. 168-175.
36. Pecego, R and Hill, R and Appelbaum, FR and Amos, D and Buckner, CD and Fefer, A and Thomas, ED. (1986) Interstitial pneumonitis following autologous bone marrow transplantation Transplantation, 42(5), pp. 515-517.
37. Nusair, S and Breuer, R and Shapira, MY and Berkman, N and Or, R. (2004) Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. [see comment] Eur Respir J, 23(3), pp. 440-445.
38. Granena, A and Carreras, E and Rozman, C and Salgado, C and Sierra, J and Algara, M and Rovira, M and Valls, A. (1993) Interstitial pneumonitis after BMT: 15 years experience in a single institution Bone Marrow Transplant, 11(6), pp. 453-458.
39. Crawford, SW and Longton, G and Storb, R. (1993) Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia Bone Marrow Transplant, 12(3), pp. 225-231.
40. Atkinson, K and Nivison-Smith, I and Dodds, A and Concannon, A and Milliken, S and Downs, K. (1998) A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989 Bone Marrow Transplant, 21(7), pp. 691-695.
41. Kantrow, SP and Hackman, RC and Boeckh, M and Myerson, D and Crawford, SW. (1997) Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation Transplantation, 63(8), pp. 1079-1086.
42. Fukuda, T and Hackman, RC and Guthrie, KA and Sandmaier, BM and Boeckh, M and Maris, MB and Maloney, DG and Deeg, HJ and Martin, PJ and Storb, RF and and others. (2003) Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation Blood, 102(8), pp. 2777-2785.
43. Aronin, PA and Mahaley, MS, Jr and Rudnick, SA and Dudka, L and Donohue, JF and Selker, RG and Moore, P. (1980) Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: An assessment of risk factors N Engl J Med, 303(4), pp. 183-188.
44. Wheeler, C and Antin, JH and Churchill, WH and Come, SE and Smith, BR and Bubley, GJ and Rosenthal, DS and Rappaport, JM and Ault, KA and Schnipper, LE and and others. (1990) Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: A dose-finding study J Clin Oncol, 8(4), pp. 648-656.
45. Deeg, HJ and Storer, B and Slattery, JT and Anasetti, C and Doney, KC and Hansen, JA and Kiem, HP and Martin, PJ and Petersdorf, E and Radich, JP and and others. (2002) Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome Blood, 100(4), pp. 1201-1207.
46. Radich, JP and Gooley, T and Bensinger, W and Chauncey, T and Clift, R and Flowers, M and Martin, P and Slattery, J and Sultan, D and Appelbaum, FR. (2003) HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen Blood, 102(1), pp. 31-35.
47. Hartman, AR and Williams, SF and Dillon, JJ. (1998) Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: A meta-analysis Bone Marrow Transplant, 22(5), pp. 439-443.
48. Petersen, FB and Deeg, HJ and Buckner, CD and Appelbaum, FR and Storb, R and Clift, RA and Sanders, JE and Bensinger, WI and Witherspoon, RP and Sullivan, KM and and others. (1992) Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide - A phase I trial Int J Radiat Oncol Biol Phys, 23(5), pp. 1027-1032.
49. Ozsahin, M and Belkacemi, Y and Pene, F and Laporte, J and Rio, B and Leblond, V and Korbas, D and Touboul, E and Gorin, NC and Schlienger, M and and others. (1996) Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation Int J Radiat Oncol Biol Phys, 34(1), pp. 71-77.
50. Wong, R and Rondon, G and Saliba, RM and Shannon, VR and Giralt, SA and Champlin, RE and Ueno, NT. (2003) Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer Bone Marrow Transplant, 31(12), pp. 1157-1163.
51. Cooke, KR and Hill, GR and Gerbitz, A and Kobzik, L and Martin, TR and Crawford, JM and Brewer, JP and Ferrara, JL. (2000) Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation Transplantation, 70(2), pp. 272-279.
52. Clark, JG and Madtes, DK and Martin, TR and Hackman, RC and Farrand, AL and Crawford, SW. (1999) Idiopathic pneumonia after bone marrow transplantation: Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. [see comment] Crit Care Med, 27(9), pp. 1800-1806.
53. Yanik, G and Hellerstedt, B and Custer, J and Hutchinson, R and Kwon, D and Ferrara, JL and Uberti, J and Cooke, KR. (2002) Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant, 8(7), pp. 395-400.
54. Yanik, GA and Levine, JE and Ferrara, JLM and Uberti, JP and Ho, VT and Antin, JH and Cooke, KR. (2004) Survival following etanercept therapy for the treatment of idiopathic pneumonia syndrome post allogeneic stem cell transplantation Blood, 104(11), pp. 354.
55. Robbins, RA and Linder, J and Stahl, MG and Thompson, AB, III and Haire, W and Kessinger, A and Armitage, JO and Arneson, M and Woods, G and Vaughan, WP and and others. (1989) Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. [see comment] Am J Med, 87(5), pp. 511-518.
56. Afessa, B and Tefferi, A and Litzow, MR and Peters, SG. (2002) Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients Am J Respir Crit Care Med, 166(10), pp. 1364-1368.
57. Chao, NJ and Duncan, SR and Long, GD and Horning, SJ and Blume, KG. (1991) Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients Ann Int Med, 114(2), pp. 145-146.
58. Sisson, JH and Thompson, AB and Anderson, JR and Robbins, RA and Spurzem, JR and Spence, PR and Reed, EC and Armitage, JO and Vose, JM and Arneson, MA and and others. (1992) Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease Am Rev Respir Dis, 146(2), pp. 439-443.
59. Metcalf, JP and Rennard, SI and Reed, EC and Haire, WD and Sisson, JH and Walter, T and Robbins, RA. (1994) Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group Am J Med, 96(4), pp. 439-443.
60. Agusti, C and Ramirez, J and Picado, C and Xaubet, A and Carreras, E and Ballester, E and Torres, A and Battochia, C and Rodriguez-Roisin, R. (1995) Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study Am J Respir Crit Care Med, 151(4), pp. 1006-1010.
61. Lewis, ID and DeFor, T and Weisdorf, DJ. (2000) Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: Cryptic etiology and uncertain therapy Bone Marrow Transplant, 26(5), pp. 539-543.
62. Raptis, A and Mavroudis, D and Suffredini, A and Molldrem, J and Rhee, FV and Childs, R and Phang, S and Barrett, A. (1999) High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients Bone Marrow Transplant, 24(8), pp. 879-883.
63. Wojno, KJ and Vogelsang, GB and Beschorner, WE and Santos, GW. (1994) Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease Transplantation, 57(1), pp. 88-92.
64. Witte, RJ and Gurney, JW and Robbins, RA and Linder, J and Rennard, SI and Arneson, M and Vaughan, WP and Reed, EC and Dicke, KA. (1991) Diffuse pulmonary alveolar hemorrhage after bone marrow transplantation: Radiographic findings in 39 patients Am J Roentgenol.
65. Golde, DW and Drew, WL and Klein, HZ and Finley, TN and Cline, MJ. (1975) Occult pulmonary haemorrhage in leukaemia Br Med J, 2(5964), pp. 166-168.
66. Afessa, B and Tefferi, A and Litzow, MR and Krowka, MJ and Wylam, ME and Peters, SG. (2002) Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients Am J Respir Crit Care Med, 166(5), pp. 641-645.
67. Sherman, JM and Winnie, G and Thomassen, MJ and Abdul-Karim, FW and Boat, TF. (1984) Time course of hemosiderin production and clearance by human pulmonary macrophages Chest, 86(3), pp. 409-411.
68. Hicks, K and Peng, D and Gajewski, JL. (2002) Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa Bone Marrow Transplant, 30(12), pp. 975-978.
69. Henke, D and Falk, RJ and Gabriel, DA. (2004) Successful treatment of diffuse alveolar hemorrhage with activated factor VII Ann Int Med, 140(6), pp. 493-494.
70. Lee, CK and Gingrich, RD and Hohl, RJ and Ajram, KA. (1995) Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation Bone Marrow Transplant, 16(1), pp. 175-182.
71. Horn, TD. (1994) Acute cutaneous eruptions after marrow ablation: Roses by other names? J Cutan Pathol, 21(5), pp. 385-392.
72. Bayer-Garner, IB and Smoller, BR. (2003) The spectrum of cutaneous disease in multiple myeloma J Am Acad Dermatol, 48(4), pp. 497-507.
73. Bauer, DJ and Hood, AF and Horn, TD. (1993) Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery Arch Dermatol, 129(7), pp. 855-858.
74. Maiolino, A and Biasoli, I and Lima, J and Portugal, AC and Pulcheri, W and Nucci, M. (2003) Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria Bone Marrow Transplant, 31(5), pp. 393-397.
75. Spitzer, TR. (2001) Engraftment syndrome following hematopoietic stem cell transplantation Bone Marrow Transplant, 27(9), pp. 893-898.
76. Edenfield, WJ and Moores, LK and Goodwin, G and Lee, N. (2000) An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose Bone Marrow Transplant, 25(4), pp. 405-409.
77. Akasheh, M and Eastwood, D and Vesole, DH. (2003) Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF) Bone Marrow Transplant, 31(2), pp. 113-116.
78. Madero, L and Vicent, MG and Sevilla, J and Prudencio, M and Rodriguez, F and Diaz, MA. (2002) Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation Bone Marrow Transplant, 30(6), pp. 355-358.
79. Salat, C and Holler, E and Schleuning, M and Eisele, B and Reinhardt, B and Kolb, H and Pihusch, R and Domrath, R and Hiller, E. (1995) Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation Ann Hematol, 71(6), pp. 271-274.
80. Ravoet, C and Feremans, W and Husson, B and Majois, F and Kentos, A and Lambermont, M and Wallef, G and Capel, P and Beauduin, M and Delannoy, A. (1996) Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation Bone Marrow Transplant, 18(5), pp. 943-947.
81. Capizzi, SA and Kumar, S and Huneke, NE and Gertz, MA and Inwards, DJ and Litzow, MR and Lacy, MQ and Gastineau, DA and Prakash, UB and Tefferi, A. (2001) Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation Bone Marrow Transplant, 27(12), pp. 1299-1303.
82. Donowitz, GR and Harman, C and Pope, T and Stewart, FM. (1991) The role of the chest roentgenogram in febrile neutropenic patients Arch Int Med, 151(4), pp. 701-704.
83. Roy, V and Ali, LI and Selby, GB. (2000) Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation Am J Hematol, 64(3), pp. 170-174.
84. Heussel, CP and Kauczor, HU and Heussel, GE and Fischer, B and Begrich, M and Mildenberger, P and Thelen, M. (1999) Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: Use of high-resolution computed tomography J Clin Oncol, 17(3), pp. 796-805.
85. Barloon, TJ and Galvin, JR and Mori, M and Stanford, W and Gingrich, RD. (1991) High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms Chest, 99(4), pp. 928-933.
86. Jantunen, E and Ruutu, P and Niskanen, L and Volin, L and Parkkali, T and Koukila-Kahkola, P and Ruutu, T. (1997) Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplant, 19(8), pp. 801-808.
87. Hebart, H and Loffler, J and Meisner, C and Serey, F and Schmidt, D and Bohme, A and Martin, H and Engel, A and Bunje, D and Kern, WV and and others. (2000) Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening J Infect Dis, 181(5), pp. 1713-1719.
88. Williamson, EC and Leeming, JP and Palmer, HM and Steward, CG and Warnock, D and Marks, DI and Millar, MR. (2000) Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction Br J Haematol, 108(1), pp. 132-139.
89. Reiss, E and Obayashi, T and Orle, K and Yoshida, M and Zancope-Oliveira, RM. (2000) Non-culture based diagnostic tests for mycotic infections Med Mycol, 38(Suppl. 1), pp. 147-159.
90. Rohrlich, P and Sarfati, J and Mariani, P and Duval, M and Carol, A and Saint-Martin, C and Bingen, E and Latge, JP and Vilmer, E. (1996) Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis Pediatr Infect Dis J, 15(3), pp. 232-237.
91. Stynen, D and Sarfati, J and Goris, A and Prevost, MC and Lesourd, M and Kamphuis, H and Darras, V and Latge, JP. (1992) Rat monoclonal antibodies against Aspergillus galactomannan Infect Immun, 60(6), pp. 2237-2245.
92. Sulahian, A and Touratier, S and Ribaud, P. (2003) False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam N Engl J Med, 349(24), pp. 2366-2367.
93. Verweij, PE and Weemaes, CM and Curfs, JH and Bretagne, S and Meis, JF. (2000) Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis J Clin Microbiol, 38(10), pp. 3900-3901.
94. Becker, MJ and Lugtenburg, EJ and Cornelissen, JJ and Van Der Schee, C and Hoogsteden, HC and De Marie, S. (2003) Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis Br J Haematol, 121(3), pp. 448-457.
95. Herbrecht, R and Letscher-Bru, V and Oprea, C and Lioure, B and Waller, J and Campos, F and Villard, O and Liu, KL and Natarajan-Ame, S and Lutz, P and and others. (2002) Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients J Clin Oncol, 20(7), pp. 1898-1906.
96. Petraitiene, R and Petraitis, V and Groll, AH and Sein, T and Piscitelli, S and Candelario, M and Field-Ridley, A and Avila, N and Bacher, J and Walsh, TJ. (2001) Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia Antimicrob Agents Chemother, 45(3), pp. 857-869.
97. Sulahian, A and Boutboul, F and Ribaud, P and Leblanc, T and Lacroix, C and Derouin, F. (2001) Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study Cancer, 91(2), pp. 311-318.
98. Maertens, J and Van Eldere, J and Verhaegen, J and Verbeken, E and Verschakelen, J and Boogaerts, M. (2002) Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients J Infect Dis, 186(9), pp. 1297-1306.
99. Ascioglu, S and Rex, JH and de Pauw, B and Bennett, JE and Bille, J and Crokaert, F and Denning, DW and Donnelly, JP and Edwards, JE and Erjavec, Z and and others. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus Clin Infect Dis, 34(1), pp. 7-14.
100. Mennink-Kersten, MA and Donnelly, JP and Verweij, PE. (2004) Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis Lancet Infect Dis, 4(6), pp. 349-357.
101. Schmidt, GM and Horak, DA and Niland, JC and Duncan, SR and Forman, SJ and Zaia, JA. (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The city of Hope-Stanford-Syntex CMV study group N Engl J Med, 324(15), pp. 1005-1011.
102. Crawford, SW and Bowden, RA and Hackman, RC and Gleaves, CA and Meyers, JD and Clark, JG. (1988) Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture Ann Int Med, 108(2), pp. 180-185.
103. Slavin, MA and Gleaves, CA and Schoch, HG and Bowden, RA. (1992) Quantification of cytomegalovirus in bronchoalveolar lavage fluid after allogeneic marrow transplantation by centrifugation culture J Clin Microbiol, 30(11), pp. 2776-2779.
104. Hakki, M and Riddell, SR and Storek, J and Carter, RA and Stevens-Ayers, T and Sudour, P and White, K and Corey, L and Boeckh, M. (2003) Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: Impact of host factors, drug therapy, and subclinical reactivation Blood, 102(8), pp. 3060-3067.
105. Li, CR and Greenberg, PD and Gilbert, MJ and Goodrich, JM and Riddell, SR. (1994) Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis Blood, 83(7), pp. 1971-1979.
106. Boeckh, M and Leisenring, W and Riddell, SR and Bowden, RA and Huang, ML and Myerson, D and Stevens-Ayers, T and Flowers, ME and Cunningham, T and Corey, L. (2003) Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity Blood, 101(2), pp. 407-414.
107. Gleaves, CA and Smith, TF and Shuster, EA and Pearson, GR. (1984) Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen J Clin Microbiol, 19(6), pp. 917-919.
108. Boeckh, M and Bowden, RA and Goodrich, JM and Pettinger, M and Meyers, JD. (1992) Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation Blood, 80(5), pp. 1358-1364.
109. Boeckh, M and Bowden, RA and Gooley, T and Myerson, D and Corey, L. (1999) Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients Blood, 93(5), pp. 1781-1782.
110. Gerna, G and Percivalle, E and Torsellini, M and Revello, MG. (1998) Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes J Clin Microbiol, 36(12), pp. 3585-3589.
111. Einsele, H and Ehninger, G and Hebart, H and Wittkowski, KM and Schuler, U and Jahn, G and Mackes, P and Herter, M and Klingebiel, T and Loffler, J and and others. (1995) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation Blood, 86(7), pp. 2815-2820.
112. Boeckh, M and Gallez-Hawkins, GM and Myerson, D and Zaia, JA and Bowden, RA. (1997) Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture Transplantation, 64(1), pp. 108-113.
113. Von Muller, L and Hampl, W and Hinz, J and Meisel, H and Reip, A and Engelmann, E and Heilbronn, R and Gartner, B and Kramer, O and Einsele, H and and others. (2002) High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay J Clin Microbiol, 40(6), pp. 2285-2287.
114. Weinberg, A and Schissel, D and Giller, R. (2002) Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients J Clin Microbiol, 40(11), pp. 4203-4206.
115. Preiser, W and Brauninger, S and Schwerdtfeger, R and Ayliffe, U and Garson, JA and Brink, NS and Franck, S and Doerr, HW and Rabenau, HF. (2001) Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants J Clin Virol, 20(1-2), pp. 59-70.
116. Hebart, H and Muller, C and Loffler, J and Jahn, G and Einsele, H. (1996) Monitoring of CMV infection: A comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation Bone Marrow Transplant, 17(5), pp. 861-868.
117. Timsit, JF and Misset, B and Goldstein, FW and Vaury, P and Carlet, J. (1995) Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia Chest, 108(6), pp. 1632-1639.
118. Meduri, GU and Chastre, J. (1992) The standardization of bronchoscopic techniques for ventilator-associated pneumonia Chest, 102(5 Suppl. 1), pp. 557S-564S.
119. Stover, DE and Zaman, MB and Hajdu, SI and Lange, M and Gold, J and Armstrong, D. (1984) Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host Ann Int Med, 101(1), pp. 1-7.
120. Milburn, HJ and Prentice, HG and du Bois, RM. (1987) Role of bronchoalveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants Thorax, 42(10), pp. 766-772.
121. Cordonnier, C and Bernaudin, JF and Bierling, P and Huet, Y and Vernant, JP. (1986) Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients Cancer, 58(5), pp. 1047-1054.
122. Cordonnier, C and Bernaudin, JF and Fleury, J and Feuilhade, M and Haioun, C and Payen, D and Huet, Y and Atassi, K and Vernant, JP. (1985) Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation Am Rev Respir Dis, 132(5), pp. 1118-1123.
123. Heurlin, N and Lonnqvist, B and Tollemar, J and Ehrnst, A. (1989) Fiberoptic bronchoscopy for diagnosis of opportunistic pulmonary infections after bone marrow transplantation Scand J Inf Dis, 21(4), pp. 359-366.
124. Rano, A and Agusti, C and Jimenez, P and Angrill, J and Benito, N and Danes, C and Gonzalez, J and Rovira, M and Pumarola, T and Moreno, A and and others. (2001) Pulmonary infiltrates in non-HIV immunocompromised patients: A diagnostic approach using non-invasive and bronchoscopic procedures. [see comment] Thorax, 56(5), pp. 379-387.
125. Gruson, D and Hilbert, G and Valentino, R and Vargas, F and Chene, G and Bebear, C and Allery, A and Pigneux, A and Gbikpi-Benissan, G and Cardinaud, JP. (2000) Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates Crit Care Med, 28(7), pp. 2224-2230.
126. Dunagan, DP and Baker, AM and Hurd, DD and Haponik, EF. (1997) Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation Chest, 111(1), pp. 135-141.
127. Feinstein, MB and Mokhtari, M and Ferreiro, R and Stover, DE and Jakubowski, A. (2001) Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: Findings in the era of serum cytomegalovirus antigen surveillance Chest, 120(4), pp. 1094-1100.
128. Glazer, M and Breuer, R and Berkman, N and Lossos, IS and Kapelushnik, J and Nagler, A and Naparstek, E and Kramer, MR and Lafair, J and Engelhard, D and and others. (1998) Use of fiberoptic bronchoscopy in bone marrow transplant recipients Acta Haematol, 99(1), pp. 22-26.
129. White, P and Bonacum, JT and Miller, CB. (1997) Utility of fiberoptic bronchoscopy in bone marrow transplant patients Bone Marrow Transplant, 20(8), pp. 681-687.
130. Hofmeister, CC and Forsythe, S and Czerlanis, C and Stiff, P. (2004)
131. White, DA and Wong, PW and Downey, R. (2000) The utility of open lung biopsy in patients with hematologic malignancies Am J Respir Crit Care Med, 161(3 Pt 1), pp. 723-729.
132. Hachem, RY and Boktour, MR and Hanna, HA and Tarrand, JJ and Kontoyiannis, DP and Raad, I. (2004) Serum galactomannan (GM): Which assay (ELISA or LATEX) is useful in diagnosing invasive aspergillosis Proc Inf Dis Soc Am, pp. 162. (Abstract 617)
133. Lewis, JS and Laurel, YM and Patterson, JE and Jorgensen, JH. (2004) Impact of fluconazole disk diffusion susceptibility testing on antifungal use in a university teaching hospital Proc. Inf Dis Soc Am, pp. 163. (Abstract 624)
134. Leung, AY and Suen, CK and Lie, AK and Liang, RH and Yuen, KY and Kwong, YL. (2001) Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation Blood, 98(6), pp. 1971-1978.
135. Azzi, A and Cesaro, S and Laszlo, D and Zakrzewska, K and Ciappi, S and De Santis, R and Fanci, R and Pesavento, G and Calore, E and Bosi, A. (1999) Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients J Clin Virol, 14(2), pp. 79-86.
136. Caserta, MT and Mock, DJ and Dewhurst, S. (2001) Human herpesvirus 6 Clin Infect Dis, 33(6), pp. 829-833.
137. Zerr, DM and Gooley, TA and Yeung, L and Huang, ML and Carpenter, P and Wade, JC and Corey, L and Anasetti, C. (2001) Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients Clin Infect Dis, 33(6), pp. 763-771.
138. Cone, RW and Huang, ML and Corey, L and Zeh, J and Ashley, R and Bowden, R. (1999) Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virologic manifestations J Inf Dis, 179(2), pp. 311-318.
139. Wainwright, MS and Martin, PL and Morse, RP and Lacaze, M and Provenzale, JM and Coleman, RE and Morgan, MA and Hulette, C and Kurtzberg, J. (2001) Bushnell C and others. Human herpesvirus 6 limbic encephalitis after stem cell transplantation Ann Neurol, 50(5), pp. 612-619.
140. Zerr, DM and Corey, L and Kim, HW and Huang, ML and Nguy, L and Boeckh, M. (2004) Human herpesvirus 6 (HHV-6) associated disease follwoing hematopoietic cell transplantation (HCT) Proc Inf Dis Soc Am, pp. 167. (Abstract 643)